| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| HumanPheno | Conjugated hyperbilirubinemia | 2.15e-05 | 38 | 47 | 5 | HP:0002908 | |
| HumanPheno | Elevated gamma-glutamyltransferase level | 6.17e-05 | 47 | 47 | 5 | HP:0030948 | |
| HumanPheno | Abnormal gamma-glutamyltransferase level | 6.84e-05 | 48 | 47 | 5 | HP:0034444 | |
| HumanPheno | Intrahepatic cholestasis | 6.98e-05 | 25 | 47 | 4 | HP:0001406 | |
| HumanPheno | Abnormal liver physiology | 8.20e-05 | 26 | 47 | 4 | HP:0031865 | |
| Domain | Transmemb_17 | 8.66e-05 | 3 | 101 | 2 | PF09799 | |
| Domain | Uncharacterised_TM-17 | 8.66e-05 | 3 | 101 | 2 | IPR019184 | |
| Domain | DUF4704 | 2.86e-04 | 5 | 101 | 2 | IPR031570 | |
| Domain | DUF4704 | 2.86e-04 | 5 | 101 | 2 | PF15787 | |
| Domain | PH_BEACH | 4.28e-04 | 6 | 101 | 2 | PF14844 | |
| Domain | Anoct_dimer | 5.97e-04 | 7 | 101 | 2 | PF16178 | |
| Domain | Anoct_dimer | 5.97e-04 | 7 | 101 | 2 | IPR032394 | |
| Domain | PInositol-4-P-5-kinase | 5.97e-04 | 7 | 101 | 2 | IPR023610 | |
| Domain | PH-BEACH_dom | 7.94e-04 | 8 | 101 | 2 | IPR023362 | |
| Domain | PIPKc | 7.94e-04 | 8 | 101 | 2 | SM00330 | |
| Domain | - | 7.94e-04 | 8 | 101 | 2 | 3.30.800.10 | |
| Domain | - | 7.94e-04 | 8 | 101 | 2 | 2.30.29.40 | |
| Domain | PIP5K | 7.94e-04 | 8 | 101 | 2 | PF01504 | |
| Domain | PIPK | 7.94e-04 | 8 | 101 | 2 | PS51455 | |
| Domain | PInositol-4-P-5-kinase_N | 7.94e-04 | 8 | 101 | 2 | IPR027484 | |
| Domain | PInositol-4-P-5-kinase_C | 7.94e-04 | 8 | 101 | 2 | IPR027483 | |
| Domain | PH_BEACH | 7.94e-04 | 8 | 101 | 2 | PS51783 | |
| Domain | - | 7.94e-04 | 8 | 101 | 2 | 3.30.810.10 | |
| Domain | PInositol-4-P-5-kinase_core | 7.94e-04 | 8 | 101 | 2 | IPR002498 | |
| Domain | BEACH_dom | 1.02e-03 | 9 | 101 | 2 | IPR000409 | |
| Domain | BEACH | 1.02e-03 | 9 | 101 | 2 | PS50197 | |
| Domain | Beach | 1.02e-03 | 9 | 101 | 2 | PF02138 | |
| Domain | - | 1.02e-03 | 9 | 101 | 2 | 1.10.1540.10 | |
| Domain | Beach | 1.02e-03 | 9 | 101 | 2 | SM01026 | |
| Domain | AAA+_ATPase | 1.11e-03 | 144 | 101 | 5 | IPR003593 | |
| Domain | AAA | 1.11e-03 | 144 | 101 | 5 | SM00382 | |
| Domain | Anoctamin | 1.27e-03 | 10 | 101 | 2 | PF04547 | |
| Domain | Anoctamin | 1.27e-03 | 10 | 101 | 2 | IPR007632 | |
| Domain | TRP_channel | 1.54e-03 | 11 | 101 | 2 | IPR004729 | |
| Domain | ARM-type_fold | 2.44e-03 | 339 | 101 | 7 | IPR016024 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.53e-03 | 14 | 101 | 2 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 2.53e-03 | 14 | 101 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.53e-03 | 14 | 101 | 2 | PF08393 | |
| Domain | AAA_8 | 2.53e-03 | 14 | 101 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 2.53e-03 | 14 | 101 | 2 | IPR011704 | |
| Domain | AAA_5 | 2.53e-03 | 14 | 101 | 2 | PF07728 | |
| Domain | DHC_fam | 2.90e-03 | 15 | 101 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 2.90e-03 | 15 | 101 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 2.90e-03 | 15 | 101 | 2 | PF03028 | |
| Domain | GPCR_2_secretin-like | 4.20e-03 | 60 | 101 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 4.20e-03 | 60 | 101 | 3 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 4.40e-03 | 61 | 101 | 3 | PS50261 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | IPPK MYH9 IARS1 NELFB CKAP5 RNF213 SRP68 NBEA TMEM80 BIRC6 QRICH2 LONRF2 PIGM | 4.02e-07 | 736 | 106 | 13 | 29676528 |
| Pubmed | MYH9 INSR NELFB RNF213 SRP68 NBEA BIRC6 CDKL5 THADA KIDINS220 NDC1 MRPS9 ANO3 | 7.38e-07 | 777 | 106 | 13 | 35844135 | |
| Pubmed | MYH9 COPA DPY19L1 IARS1 CKAP5 SRP68 BIRC6 FANCD2 GLMN THADA TMTC3 NUP93 | 8.17e-07 | 657 | 106 | 12 | 36180527 | |
| Pubmed | Organization and evolutionary relatedness of OR37 olfactory receptor genes in mouse and human. | 5.93e-06 | 12 | 106 | 3 | 12906860 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYH9 COPA TRIO IARS1 CKAP5 SRP68 FANCD2 GLMN THADA KIDINS220 NDC1 VPS33B SLC25A13 MRPS9 NUP93 AQR | 6.61e-06 | 1425 | 106 | 16 | 30948266 |
| Pubmed | The ANO3/MUC15 locus is associated with eczema in families ascertained through asthma. | 9.20e-06 | 2 | 106 | 2 | 22657408 | |
| Pubmed | 1.00e-05 | 449 | 106 | 9 | 31732153 | ||
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 1.90e-05 | 179 | 106 | 6 | 36261009 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 18716610 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 22936720 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 16600873 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 11950846 | ||
| Pubmed | Apocrine glands are bystanders in hidradenitis suppurativa and their involvement is gender specific. | 3.26e-05 | 59 | 106 | 4 | 32031713 | |
| Pubmed | A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate. | 5.50e-05 | 4 | 106 | 2 | 9367159 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 12739008 | ||
| Pubmed | 5.61e-05 | 560 | 106 | 9 | 35241646 | ||
| Pubmed | MYH9 GPAA1 COPA DPY19L1 IARS1 CKAP5 RNF213 BIRC6 KIDINS220 NDC1 NUP93 HEATR5B AQR | 5.71e-05 | 1168 | 106 | 13 | 19946888 | |
| Pubmed | COPA TRIO ITGA6 RNF213 NBEA BIRC6 FANCD2 GLMN NDC1 VPS33B NUP93 HERC1 | 8.68e-05 | 1049 | 106 | 12 | 27880917 | |
| Pubmed | Sur2 and Kcnj8 genes are tightly linked on the distal region of mouse chromosome 6. | 9.15e-05 | 5 | 106 | 2 | 9321483 | |
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 18256285 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 37172092 | ||
| Pubmed | Trio cooperates with Myh9 to regulate neural crest-derived craniofacial development. | 9.15e-05 | 5 | 106 | 2 | 33754063 | |
| Pubmed | KRT72 MYH9 COPA TRIO IARS1 CKAP5 SRP68 NBEA CDKL5 KIDINS220 CADPS MRPS9 HRG PIP4K2C | 1.15e-04 | 1431 | 106 | 14 | 37142655 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT72 MYH9 COPA IARS1 CKAP5 ITGA6 SRP68 SLC25A13 IMP4 MRPS9 RAB15 NUP93 AQR | 1.19e-04 | 1257 | 106 | 13 | 36526897 |
| Pubmed | Identification and characterization of TMEM16E and TMEM16F genes in silico. | 1.37e-04 | 6 | 106 | 2 | 15067359 | |
| Pubmed | 1.40e-04 | 494 | 106 | 8 | 26831064 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | COPA IARS1 SRP68 FANCD2 GLMN THADA KIDINS220 NDC1 TMTC3 NUP93 HEATR5B | 1.45e-04 | 942 | 106 | 11 | 31073040 |
| Pubmed | MYH9 GPAA1 COPA TRIO IARS1 SRP68 BIRC6 GLMN KIDINS220 NDC1 TMTC3 SDC2 AQR | 1.62e-04 | 1297 | 106 | 13 | 33545068 | |
| Pubmed | 1.91e-04 | 7 | 106 | 2 | 15018809 | ||
| Pubmed | 2.15e-04 | 38 | 106 | 3 | 22908908 | ||
| Pubmed | 2.47e-04 | 285 | 106 | 6 | 34369648 | ||
| Pubmed | 2.55e-04 | 8 | 106 | 2 | 15046600 | ||
| Pubmed | 3.08e-04 | 105 | 106 | 4 | 30280653 | ||
| Pubmed | 3.16e-04 | 421 | 106 | 7 | 36976175 | ||
| Pubmed | 3.27e-04 | 9 | 106 | 2 | 22976293 | ||
| Pubmed | 3.27e-04 | 9 | 106 | 2 | 10452948 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MYH9 COPA IARS1 NELFB CKAP5 SRP68 BIRC6 ARHGEF7 SLC25A13 MRPS9 UPP1 PIP4K2C AQR | 3.76e-04 | 1415 | 106 | 13 | 28515276 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.96e-04 | 202 | 106 | 5 | 33005030 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | GPAA1 SGCD ITGA6 RNF213 FBXO46 FANCD2 THADA NDC1 ZDHHC9 NUP93 HERC1 | 4.01e-04 | 1061 | 106 | 11 | 33845483 |
| Pubmed | 4.05e-04 | 47 | 106 | 3 | 8812413 | ||
| Pubmed | 4.05e-04 | 47 | 106 | 3 | 29617656 | ||
| Pubmed | Anoctamin/TMEM16 family members are Ca2+-activated Cl- channels. | 4.08e-04 | 10 | 106 | 2 | 19015192 | |
| Pubmed | 4.08e-04 | 10 | 106 | 2 | 23911870 | ||
| Pubmed | Calcium-dependent phospholipid scramblase activity of TMEM16 protein family members. | 4.08e-04 | 10 | 106 | 2 | 23532839 | |
| Pubmed | 4.08e-04 | 10 | 106 | 2 | 24692353 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 4.21e-04 | 582 | 106 | 8 | 20467437 | |
| Pubmed | 4.57e-04 | 320 | 106 | 6 | 28685749 | ||
| Pubmed | 4.97e-04 | 11 | 106 | 2 | 20878950 | ||
| Pubmed | Immunolocalization of extracellular matrix components and integrins during mouse liver development. | 4.97e-04 | 11 | 106 | 2 | 15368439 | |
| Pubmed | 5.19e-04 | 601 | 106 | 8 | 33658012 | ||
| Pubmed | 5.46e-04 | 52 | 106 | 3 | 26590417 | ||
| Pubmed | 5.54e-04 | 332 | 106 | 6 | 25693804 | ||
| Pubmed | 5.95e-04 | 12 | 106 | 2 | 25959047 | ||
| Pubmed | 5.95e-04 | 12 | 106 | 2 | 10433923 | ||
| Pubmed | 6.08e-04 | 222 | 106 | 5 | 35941108 | ||
| Pubmed | A conserved acetylation switch enables pharmacological control of tubby-like protein stability. | 6.21e-04 | 223 | 106 | 5 | 33187986 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 6.47e-04 | 475 | 106 | 7 | 31040226 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | 6.67e-04 | 344 | 106 | 6 | 36282215 | |
| Pubmed | COPA DPY19L1 ITGA6 BIRC6 KIDINS220 NDC1 TMTC3 SLC25A13 TBC1D23 SDC2 | 6.72e-04 | 952 | 106 | 10 | 38569033 | |
| Pubmed | COPA DPY19L1 IARS1 SRP68 KIDINS220 SLC25A13 MRPS9 NUP93 PIP4K2C | 6.86e-04 | 786 | 106 | 9 | 29128334 | |
| Pubmed | Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. | 7.02e-04 | 13 | 106 | 2 | 22885925 | |
| Pubmed | DOCK3 MYH9 TRIO IARS1 CKAP5 NBEA BIRC6 CDKL5 CADPS ARHGEF7 MRPS9 | 7.22e-04 | 1139 | 106 | 11 | 36417873 | |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 7.28e-04 | 231 | 106 | 5 | 36597993 | |
| Pubmed | 8.04e-04 | 493 | 106 | 7 | 15368895 | ||
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 8.20e-04 | 358 | 106 | 6 | 32460013 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UBR1 MYH9 COPA IARS1 CKAP5 SRP68 BIRC6 VPS33B SLC25A13 NUP93 PIP4K2C AQR | 8.67e-04 | 1353 | 106 | 12 | 29467282 |
| Pubmed | 8.90e-04 | 653 | 106 | 8 | 22586326 | ||
| Pubmed | 9.09e-04 | 140 | 106 | 4 | 16778019 | ||
| Pubmed | Common body mass index-associated variants confer risk of extreme obesity. | 9.41e-04 | 15 | 106 | 2 | 19553259 | |
| Pubmed | 1.01e-03 | 513 | 106 | 7 | 25798074 | ||
| Pubmed | The RNA-methyltransferase Misu (NSun2) poises epidermal stem cells to differentiate. | 1.07e-03 | 16 | 106 | 2 | 22144916 | |
| Pubmed | 1.07e-03 | 16 | 106 | 2 | 24968937 | ||
| Pubmed | 1.07e-03 | 16 | 106 | 2 | 21343368 | ||
| Pubmed | Tissue distribution, ontogeny, and hormonal regulation of xenobiotic transporters in mouse kidneys. | 1.07e-03 | 16 | 106 | 2 | 19679677 | |
| Pubmed | 1.08e-03 | 378 | 106 | 6 | 34315543 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | GPAA1 DPY19L1 IARS1 NELFB CKAP5 ITGA6 NDC1 TMTC3 NUP93 TBC1D23 AQR | 1.12e-03 | 1203 | 106 | 11 | 29180619 |
| Pubmed | Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. | 1.14e-03 | 67 | 106 | 3 | 23263486 | |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | 1.15e-03 | 256 | 106 | 5 | 35777956 | |
| Pubmed | 1.16e-03 | 383 | 106 | 6 | 29331416 | ||
| Pubmed | Dissecting and manipulating the pathway for glycosylphos-phatidylinositol-anchor biosynthesis. | 1.21e-03 | 17 | 106 | 2 | 11102867 | |
| Pubmed | Functional screen identifies regulators of murine hematopoietic stem cell repopulation. | 1.36e-03 | 18 | 106 | 2 | 26880577 | |
| Pubmed | Putative Protein Interactome of the Rhomboid Protease RHBDL4. | 1.36e-03 | 18 | 106 | 2 | 36857408 | |
| Pubmed | 1.36e-03 | 18 | 106 | 2 | 21068128 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 1.41e-03 | 268 | 106 | 5 | 33024031 | |
| Pubmed | 1.41e-03 | 72 | 106 | 3 | 34882091 | ||
| Pubmed | Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders. | 1.41e-03 | 72 | 106 | 3 | 25917818 | |
| Pubmed | 1.41e-03 | 72 | 106 | 3 | 36376293 | ||
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 1.43e-03 | 269 | 106 | 5 | 29511261 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 1.43e-03 | 704 | 106 | 8 | 29955894 | |
| Pubmed | 1.48e-03 | 878 | 106 | 9 | 37223481 | ||
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 1.50e-03 | 272 | 106 | 5 | 25315684 | |
| Pubmed | 1.52e-03 | 19 | 106 | 2 | 23118302 | ||
| Pubmed | A novel custom resequencing array for dilated cardiomyopathy. | 1.52e-03 | 19 | 106 | 2 | 20474083 | |
| Pubmed | 1.52e-03 | 19 | 106 | 2 | 19767753 | ||
| Pubmed | Odorant and vomeronasal receptor genes in two mouse genome assemblies. | 1.52e-03 | 74 | 106 | 3 | 15081110 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | 1.54e-03 | 552 | 106 | 7 | 10737800 | |
| Pubmed | Fine mapping of collagen-induced arthritis quantitative trait loci in an advanced intercross line. | 1.69e-03 | 20 | 106 | 2 | 17082620 | |
| Pubmed | 1.69e-03 | 20 | 106 | 2 | 20564319 | ||
| Pubmed | Proteomic analysis reveals novel ligands and substrates for LNX1 E3 ubiquitin ligase. | 1.84e-03 | 79 | 106 | 3 | 29121065 | |
| Pubmed | 1.86e-03 | 21 | 106 | 2 | 31541095 | ||
| Interaction | ARL10 interactions | 4.60e-06 | 189 | 100 | 8 | int:ARL10 | |
| Interaction | APLNR interactions | 1.03e-05 | 211 | 100 | 8 | int:APLNR | |
| Cytoband | 3q12.2 | 1.92e-04 | 9 | 107 | 2 | 3q12.2 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 5.84e-04 | 9 | 74 | 2 | 1230 | |
| GeneFamily | Anoctamins | 7.28e-04 | 10 | 74 | 2 | 865 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-07 | 167 | 106 | 7 | b4ef07117d14da3d5fbced949e4dfcb01c392295 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-07 | 167 | 106 | 7 | 94fc7df7ca55cd722a8dbd153201a29891217473 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-07 | 167 | 106 | 7 | eff3723fe60755272eca237459165e436e919ece | |
| ToppCell | droplet-Bladder-Unstain-18m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-07 | 186 | 106 | 7 | e3a14f3ccadbf3211822c67b8956ee01f563307a | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.19e-07 | 200 | 106 | 7 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.19e-07 | 200 | 106 | 7 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Migrating_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.95e-06 | 155 | 106 | 6 | 1882fa5fd25f77d6e3ac47b613f6fb3c67d8e50c | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-06 | 163 | 106 | 6 | 1eec7f5e5fed05fa21d3f81db588f10605f08ea7 | |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 3.68e-06 | 173 | 106 | 6 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 6.11e-06 | 189 | 106 | 6 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.49e-06 | 191 | 106 | 6 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.69e-06 | 192 | 106 | 6 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.69e-06 | 192 | 106 | 6 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.89e-06 | 193 | 106 | 6 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.44e-06 | 200 | 106 | 6 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.44e-06 | 200 | 106 | 6 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 8.44e-06 | 200 | 106 | 6 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.73e-05 | 134 | 106 | 5 | 9e12aac8f42790c2f104dfd61c87aa99fc7925f1 | |
| ToppCell | CV-Mild-7|CV / Virus stimulation, Condition and Cluster | 5.41e-05 | 170 | 106 | 5 | 25ebde7d2f8ae1afdfaf5876284ff20bb179eb10 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.04e-05 | 174 | 106 | 5 | 9cc7251661ea2b1565eef1dfb8cf6dec3ade13d4 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.37e-05 | 176 | 106 | 5 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.55e-05 | 177 | 106 | 5 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 7.86e-05 | 184 | 106 | 5 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.86e-05 | 184 | 106 | 5 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.06e-05 | 185 | 106 | 5 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.06e-05 | 185 | 106 | 5 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.27e-05 | 186 | 106 | 5 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.48e-05 | 187 | 106 | 5 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | COPD-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 8.48e-05 | 187 | 106 | 5 | 406ecd1dabb3ed8d871aef159f7bd1e383434953 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.48e-05 | 187 | 106 | 5 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.70e-05 | 188 | 106 | 5 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.92e-05 | 189 | 106 | 5 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 9.37e-05 | 191 | 106 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.37e-05 | 191 | 106 | 5 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.37e-05 | 191 | 106 | 5 | 1626b23a57429f835fddc052e3c57f63a4e5b8bb | |
| ToppCell | control-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.37e-05 | 191 | 106 | 5 | afebdc59a1f884ce3f2f5fe040e16b0e95e4e7c5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.37e-05 | 191 | 106 | 5 | 716dfa7fccbd62b5f574792e68a26dc6c45511dc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.60e-05 | 192 | 106 | 5 | 24e2f15f5767a97eb3b389922bcfd7b13805e1ce | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.60e-05 | 192 | 106 | 5 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.60e-05 | 192 | 106 | 5 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | IPF-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 1.01e-04 | 194 | 106 | 5 | 3892b188f424ffb80f3c75a1b6709a21c1e1601d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.01e-04 | 194 | 106 | 5 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-04 | 195 | 106 | 5 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-04 | 195 | 106 | 5 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 1.06e-04 | 196 | 106 | 5 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-04 | 196 | 106 | 5 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-04 | 196 | 106 | 5 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.11e-04 | 198 | 106 | 5 | 76d46950c11cb4708866db0da54ce00d5c0adab8 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.14e-04 | 199 | 106 | 5 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | distal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-04 | 200 | 106 | 5 | 911db29f254bb697610e720ba78816e2c7f57933 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 106 | 5 | aafe594c88710f8c53d59667cdac5035e08f5511 | |
| ToppCell | distal-mesenchymal-Pericyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-04 | 200 | 106 | 5 | fe31287cfb51d45643bdedbaa5efc03ed87263c6 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | distal-mesenchymal-Pericyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-04 | 200 | 106 | 5 | 867935701fac71a3fe01578362da0676f959736c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 106 | 5 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 106 | 5 | a6f0f5f644b7262878b0b9d4d90ee407c4124dd9 | |
| ToppCell | distal-2-mesenchymal-Pericyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.16e-04 | 200 | 106 | 5 | 4ee0b2f56c2652435fa78bf6b3c90cea28df74e0 | |
| Disease | uric acid measurement | IPPK INSR BIRC6 QRICH2 GLMN CCM2 NDC1 PIP5K1B ABCG2 SLC41A1 HCRTR2 | 7.97e-06 | 610 | 101 | 11 | EFO_0004761 |
| Disease | Drug habituation | 4.84e-05 | 115 | 101 | 5 | C0013170 | |
| Disease | Drug abuse | 4.84e-05 | 115 | 101 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 4.84e-05 | 115 | 101 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 4.84e-05 | 115 | 101 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 4.84e-05 | 115 | 101 | 5 | C0013222 | |
| Disease | Drug Dependence | 4.84e-05 | 115 | 101 | 5 | C1510472 | |
| Disease | Substance Dependence | 4.84e-05 | 115 | 101 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 4.84e-05 | 115 | 101 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.84e-05 | 115 | 101 | 5 | C0029231 | |
| Disease | Substance abuse problem | 5.05e-05 | 116 | 101 | 5 | C0740858 | |
| Disease | age at diagnosis, substance-related disorder | 1.72e-04 | 6 | 101 | 2 | EFO_0004918, MONDO_0002494 | |
| Disease | waist-hip ratio | IPPK SGCD INSR BIRC6 THADA CCM2 KIDINS220 CADPS EPC1 RAB15 TBC1D23 LONRF2 ANO3 | 2.83e-04 | 1226 | 101 | 13 | EFO_0004343 |
| Disease | Cleft palate, cleft lip | 4.05e-04 | 279 | 101 | 6 | EFO_0003959, HP_0000175 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 6.25e-04 | 11 | 101 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | receptor-interacting serine/threonine-protein kinase 2 measurement | 6.25e-04 | 11 | 101 | 2 | EFO_0802997 | |
| Disease | Metastatic melanoma | 8.51e-04 | 54 | 101 | 3 | C0278883 | |
| Disease | Nephronophthisis | 8.83e-04 | 13 | 101 | 2 | C0687120 | |
| Disease | urolithiasis | 1.33e-03 | 63 | 101 | 3 | MONDO_0024647 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 1.71e-03 | 18 | 101 | 2 | HP_0002373 | |
| Disease | Cleft palate | 1.88e-03 | 71 | 101 | 3 | HP_0000175 | |
| Disease | uridine diphosphate measurement | 2.12e-03 | 20 | 101 | 2 | EFO_0010545 | |
| Disease | Familial aplasia of the vermis | 2.12e-03 | 20 | 101 | 2 | cv:C0431399 | |
| Disease | risky sexual behaviour measurement | 2.75e-03 | 169 | 101 | 4 | EFO_0007877 | |
| Disease | hippocampal sclerosis of aging | 2.80e-03 | 23 | 101 | 2 | EFO_0005678 | |
| Disease | metabolite measurement | 3.17e-03 | 560 | 101 | 7 | EFO_0004725 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TDNKIMLELARLYLA | 916 | Q7Z4L5 | |
| LLHLTLEIMEKRYNL | 261 | Q9H2F5 | |
| MTLAQLLTLLYDRKL | 3981 | Q9NR09 | |
| MGVSKLDILYRRLLL | 1 | Q0P651 | |
| MIVIFLTIAYLKLLF | 636 | Q9UNQ0 | |
| LSNLRYLMKFLARLA | 396 | Q9Y3L3 | |
| MLFKALLIIYGILVI | 491 | Q8IZF3 | |
| YLEKALLDMRALLQS | 606 | P43155 | |
| ALLAMIYNKILRLST | 386 | O60706 | |
| KNERYLLLFPNVLLM | 496 | Q14155 | |
| IRKIMLLEFSQYLEN | 61 | O60306 | |
| TELLQDYMLTLRTKL | 296 | Q9BSQ5 | |
| LSAAQLYYLLIRTMK | 546 | Q96K78 | |
| IIMLLNVLYEKVALL | 561 | Q32M45 | |
| ILLNMYASILLLATI | 116 | P21730 | |
| IIMLLNLAYEKIAYL | 606 | Q9BYT9 | |
| KIYLQVLSFLLLGLM | 386 | P36021 | |
| LNFVRLLMLYTRKFE | 526 | Q8N1F7 | |
| RTLVSKIYELLFMNL | 1641 | Q6ZS30 | |
| LIISYEMLLRSLDQI | 406 | Q9Y620 | |
| MAKQYDVLFRLLLIG | 1 | P59190 | |
| LYLQDQLDKLRMIIE | 1166 | Q9H0J4 | |
| LARMELFLYLTAILQ | 441 | P24903 | |
| LLLVALLMLRKYRKD | 446 | P25092 | |
| FELKLYMIRLGTLEQ | 251 | Q96G21 | |
| LYKTLQVQMLDLLDI | 321 | Q9H8X2 | |
| RMDLQLHIYQLKTLI | 1276 | Q9ULU8 | |
| KTFFVLILLMYLVIL | 26 | Q8NH95 | |
| KTFFVLILLMYLVIL | 26 | P0DN81 | |
| RHIGYLELLLKLMFV | 566 | Q9ULH0 | |
| MKALIAALLLITLQY | 1 | P04196 | |
| MLALAKILLISTLFY | 1 | Q8N387 | |
| MALKLVALIYLALQL | 496 | O43292 | |
| LYLIARVMLLHSKLF | 266 | Q9H2S1 | |
| ASVLLIRKLYILMQD | 156 | Q8N7B1 | |
| AEILMKTLLRNLGFY | 941 | Q15751 | |
| YTFLEDMIRVLLSKL | 4466 | Q5CZC0 | |
| FKIQRLLEPRQYMLL | 461 | Q6PJ61 | |
| KLLLFMGIIDILQSY | 341 | O14986 | |
| LQLLAYTALGILIMR | 456 | Q2PZI1 | |
| YTALGILIMRLKLFL | 461 | Q2PZI1 | |
| LLARKEIEYQELMFL | 2356 | Q6ZR08 | |
| NVKLYDMVLQFLRTL | 211 | Q8WX92 | |
| VTLLAAAMLIVFYKL | 536 | Q9HBW1 | |
| VLMIKALELDSNLYR | 741 | P35579 | |
| NSLLLLRAELYLTMK | 231 | Q1L5Z9 | |
| LSFPKLIMITDYLLL | 76 | P06213 | |
| KLNYLDILMRAFIDV | 1006 | P23229 | |
| KTFFVLILLMYLVIL | 26 | Q9NQN1 | |
| MKLLYLFLAILLAIE | 1 | Q8N690 | |
| MELTIFILRLAIYIL | 1 | Q9H8H3 | |
| LLRQLLKYDLFVSMI | 246 | Q5TIA1 | |
| LLKVPLMLTFLYLFV | 101 | Q06495 | |
| LCLMVLAYLQIFRKL | 236 | O43614 | |
| LEKLMIRLGLFTVLY | 526 | Q9H461 | |
| LMKALEYLKLLFTLL | 1261 | Q14008 | |
| AAMVRLRLYDILALL | 666 | Q9P2D3 | |
| LFYKLRHVMNELIDL | 111 | Q8IZD9 | |
| MILVLRTALNLFFKL | 1101 | P53621 | |
| FLARKRLLEYMGLQL | 811 | Q9P2S6 | |
| SRYFLEMQEKLERLL | 236 | O60307 | |
| LIIALIQMFKIVLEY | 521 | Q8NCS7 | |
| LMEIKQLLVILLTYF | 456 | O75881 | |
| RASLLYFIMNDLSKI | 3681 | Q9NYC9 | |
| RYLGILNSVLLDLMK | 261 | O76039 | |
| IFLILLLVYRMRKKD | 161 | P34741 | |
| MAFELLSIDLYELIK | 286 | O43781 | |
| ALYLIRLLMVILEKS | 1131 | Q9BXW9 | |
| EFLVQLKIMDYSLLL | 271 | Q8TBX8 | |
| LLMGFSNIQKLRILY | 11 | Q96R54 | |
| LIYLAALMSNLLIIT | 31 | Q96R54 | |
| FYNIIFRRLLKIMNL | 211 | Q96J94 | |
| IMASLNLLRYLVIKD | 471 | Q92990 | |
| SIMLHELIKLLYYAR | 116 | Q16831 | |
| IILMLLLFLYINKKF | 36 | Q8NB59 | |
| FLLLLVLERLYASPM | 1321 | Q6YHU6 | |
| RYLVLDLALLFLMGI | 126 | Q96HE8 | |
| LISYFLILNTILKMS | 266 | Q8NGC0 | |
| EIISLRAFMLLFLKQ | 676 | Q8NFP9 | |
| LFLTLLMLEAAYKLL | 41 | Q5STR5 | |
| MTAALLQVLILLYIA | 446 | Q8IVJ1 | |
| LILMEARLSALYKLE | 256 | P41252 | |
| LTYTMILNLLRVDAL | 746 | Q15477 | |
| LSYLLILVAILRMNS | 216 | Q8NH51 | |
| EILRYMKEFTLLLSA | 271 | Q15391 | |
| ELLTDNRYLLLVLMD | 116 | Q9UHB9 | |
| MLGSLYKILENILII | 71 | Q01718 | |
| YKILENILIILRNMG | 76 | Q01718 | |
| LLNNMELIRKIYSTL | 226 | Q9UJS0 | |
| LEMLLRLLDTYRDKI | 821 | Q63HN8 | |
| MARQKGIFYLTLFLI | 31 | Q9Y397 | |
| EKLSDLDYMQFIRLL | 211 | P82933 | |
| LDYMQFIRLLEKLLT | 216 | P82933 | |
| KRCLYFFVLLLMILI | 31 | Q92629 | |
| LLLYLAFYIIMKLRS | 721 | Q9NXL6 | |
| MLRYLLKTLLQMNLF | 1 | Q96MS0 | |
| DMEKQLLYLRELLRL | 571 | Q8TBP0 | |
| YFLMLIILVNAKEVI | 231 | Q9NUY8 | |
| LKLLSPLMTRYFFLL | 6 | Q9GZP7 | |
| LLTYILLLNMLIALM | 631 | Q9Y5S1 | |
| LMDPNKFLLLVLQRY | 701 | Q8IWV7 | |
| LLYRDVMLENLALLS | 31 | Q8NEK5 | |
| ALIGLIFLMVLYLNR | 316 | P0DKB5 | |
| LTFRLNYLLSELKPM | 76 | Q6ZXV5 | |
| RLDFQLMLKIRDTLY | 56 | Q8NFY4 | |
| ASLVLMVLYLIKKRL | 151 | Q9H3S5 | |
| VMLLLYLGIEVIRLF | 61 | Q9P0N5 | |
| SMLKRLARDQLIYLL | 16 | Q9H267 | |
| RMLLDILKFLFIYCL | 511 | Q9UBN4 | |
| VQRIMKYQLLLKDFL | 2101 | O75962 | |
| LEKLEAMYRRALLQL | 161 | Q2TAM9 | |
| MLREYQELVSLKLAL | 406 | Q14CN4 | |
| IIKYLALQDLMLLSQ | 326 | Q9BTX1 |